Strong IT Capabilities to Drive South Korean Biotechnology Market
South Korea represents Asia-Pacific’s third largest biotech market after Japan and China. The country’s biotech market is dominated by major pharmaceutical corporations and smaller venture capital supported businesses. Fuelled by strong government support, increased international investments, and strong performance of the biomedicine sector, the biotech market in South Korea is forecasted to grow at a CAGR of around 21% during 2010 - 2012, says our new research report “Asia Pacific Biotechnology Market (2008-2012)”.
View full press release